GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (LSE:GSK) » Definitions » Cyclically Adjusted FCF per Share

GSK (LSE:GSK) Cyclically Adjusted FCF per Share : £1.38 (As of Mar. 2024)


View and export this data going back to 1972. Start your Free Trial

What is GSK Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

GSK's adjusted free cash flow per share for the three months ended in Mar. 2024 was £0.096. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is £1.38 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 4.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of GSK was 83.40% per year. The lowest was -0.60% per year. And the median was 5.60% per year.

As of today (2024-05-22), GSK's current stock price is £17.56. GSK's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was £1.38. GSK's Cyclically Adjusted Price-to-FCF of today is 12.72.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of GSK was 18.76. The lowest was 9.39. And the median was 13.04.


GSK Cyclically Adjusted FCF per Share Historical Data

The historical data trend for GSK's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Cyclically Adjusted FCF per Share Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 1.21 1.25 1.40 1.38

GSK Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.38 1.37 1.38 1.38

Competitive Comparison of GSK's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, GSK's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where GSK's Cyclically Adjusted Price-to-FCF falls into.



GSK Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GSK's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.096/131.6000*131.6000
=0.096

Current CPI (Mar. 2024) = 131.6000.

GSK Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.095 99.800 0.125
201409 0.219 100.000 0.288
201412 0.422 99.900 0.556
201503 0.001 99.600 0.001
201506 -0.051 100.100 -0.067
201509 0.010 100.200 0.013
201512 0.209 100.400 0.274
201603 -0.030 100.400 -0.039
201606 0.195 101.000 0.254
201609 0.324 101.500 0.420
201612 0.562 102.200 0.724
201703 0.185 102.700 0.237
201706 0.101 103.500 0.128
201709 0.355 104.300 0.448
201712 0.551 105.000 0.691
201803 0.128 105.100 0.160
201806 0.249 105.900 0.309
201809 0.414 106.600 0.511
201812 0.873 107.100 1.073
201903 0.090 107.000 0.111
201906 0.189 107.900 0.231
201909 0.513 108.400 0.623
201912 0.664 108.500 0.805
202003 0.155 108.600 0.188
202006 0.587 108.800 0.710
202009 0.053 109.200 0.064
202012 0.818 109.400 0.984
202103 -0.006 109.700 -0.007
202106 0.183 111.400 0.216
202109 0.336 112.400 0.393
202112 0.793 114.700 0.910
202203 0.485 116.500 0.548
202206 0.232 120.500 0.253
202209 0.206 122.300 0.222
202212 0.282 125.300 0.296
202303 -0.117 126.800 -0.121
202306 0.151 129.400 0.154
202309 0.417 130.100 0.422
202312 0.586 130.500 0.591
202403 0.096 131.600 0.096

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


GSK  (LSE:GSK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

GSK's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=17.56/1.38
=12.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of GSK was 18.76. The lowest was 9.39. And the median was 13.04.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


GSK Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of GSK's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (LSE:GSK) Business Description

Industry
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK (LSE:GSK) Headlines

From GuruFocus

Top 5 4th Quarter Trades of HealthInvest Partners AB

By GuruFocus Research GuruFocus Editor 02-18-2023

Haleon Proves Its Mettle After GSK Spinoff

By Margaret Moran 12-06-2022

Top 5 3rd Quarter Trades of Parallax Volatility Advisers, L.P.

By GuruFocus Research GuruFocus Editor 11-22-2022

WELCH & FORBES LLC Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-02-2023

Westchester Capital Management, LLC Buys 2, Sells 3 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-16-2022

Ridgewood Investments LLC Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-20-2023

Top 5 4th Quarter Trades of JTC Employer Solutions Trustee Ltd

By GuruFocus Research GuruFocus Editor 01-18-2023